|McElrath: Innate to Adaptive Immunity
|Combo: Protein & vector vaccines
|Study Start Date:
|Study Made Public:
Immunogenicity and challenge following prime-boost immunization with MVA-SIV Env followed by Env protein plus Poly-ICLC adjuvant in NHP
CAVD 260 is a non-human primate challenge study comparing prime/boost regimens of a Modified Vaccinia Ankara vaccine combined with envelope protein vaccine and the adjuvant, Poly-ICLC .
Sign in to see full information about this study and to download study data.